Cabaletta Bio Inc . (CABA): Sold last week .85 to 8.75-$9.00 in less...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM

Followers	3
Posts	89
Boards Moderated	0
Alias Born	08/12/2022

FREE
CABA REPORT

TechandBio

Re: None

Sunday, 12/25/2022 9:51:04 PM

Sunday, December 25, 2022 9:51:04 PM

Sold last week .85 to 8.75-$9.00 in less than 4 months.

$CABA

Bullish

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent CABA News

Current Report Filing (8-k) • Edgar (US Regulatory) • 03/31/2023 11:15:37 AM
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Systemic Lupus Erythematosus • GlobeNewswire Inc. • 03/31/2023 11:00:00 AM
Securities Registration Statement (simplified Form) (s-3) • Edgar (US Regulatory) • 03/16/2023 12:39:27 PM
Securities Registration: Employee Benefit Plan (s-8) • Edgar (US Regulatory) • 03/16/2023 11:38:22 AM
Annual Report (10-k) • Edgar (US Regulatory) • 03/16/2023 11:26:16 AM
Current Report Filing (8-k) • Edgar (US Regulatory) • 03/16/2023 11:11:54 AM
Cabaletta Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/16/2023 11:00:00 AM
Cabaletta Bio to Present at the Cowen 43rd Annual Health Care Conference • GlobeNewswire Inc. • 02/28/2023 01:00:00 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 09:24:54 PM
Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/14/2023 09:02:32 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 08:10:05 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 01:16:32 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 12:22:02 PM
Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/10/2023 09:05:08 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/09/2023 05:40:23 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 01/09/2023 12:02:53 PM
Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus’ Safety Switch System in Cell Therapies for Autoimmune Disease • GlobeNewswire Inc. • 01/09/2023 12:00:00 PM
Cabaletta Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/05/2023 01:00:00 PM
Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 12/23/2022 09:16:29 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 12/12/2022 09:53:48 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 12/08/2022 09:32:31 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 12/08/2022 12:11:26 PM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) • Edgar (US Regulatory) • 12/08/2022 12:07:44 PM
Cabaletta Bio Announces $35 Million Offering • GlobeNewswire Inc. • 12/08/2022 12:00:00 PM
Cabaletta Bio to Present at the 5th Annual Evercore ISI HealthCONx Conference • GlobeNewswire Inc. • 11/22/2022 01:00:00 PM

More CABA News

InvestorsHub NewsWire

ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM

Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM

Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • TLSA • Mar 31, 2023 7:07 AM

ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM

Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM

OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards:

Quotes:

Stock Options

Detailed Quote

Recent CABA News

More CABA News